CYCLAVANCE (cyclosporine oral solution) USP MODIFIED for Dogs
100 mg/mL
-
The effective cyclosporine you know and trust—IN LIQUID FORM
-
Easy to administer: CYCLAVANCE oral solution is a liquid only for dogs. In a study, 99% of dogs readily accepted it without the need to hide it in food.2
-
Correct dosed: Give your dog the right amount of medicine every time. Each dose is precisely tailored to your dog’s weight.
-
Practice safety and hygiene: Wear gloves during and wash hands after administration.
-
CYCLAVANCE oral solution should be given daily until improvement is seen. This will generally be the case within 30 days or less.3
Atopic dermatitis is a common skin disease in dogs caused by allergens, such as house dust mites or pollens, which trigger an exaggerated immune response. The disease is chronic or long-lasting and must be managed over the course of your dog’s life.1
CYCLAVANCE oral solution is for use only in dogs to control atopic dermatitis. It is proven to be effective and safe in reducing the itch, inflammation and skin lesions associated with atopic dermatitis—helping to return your dog to a happy state of being.1 Ask your veterinarian if CYCLAVANCE oral solution is a good option for your dog.
INDICATIONS:
CYCLAVANCE is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs (1.8 kg) body weight.
IMPORTANT SAFETY INFORMATION:
CYCLAVANCE (cyclosporine oral solution) USP Modified: For use in dogs only. Wear gloves during and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial recommended dose of CYCLAVANCE Oral Solution for Dogs. CYCLAVANCE Oral Solution for Dogs should be used with caution: 1) in cases with diabetes mellitus as it may cause elevated levels of serum glucose; 2) in dogs with renal insufficiency since the effect of cyclosporine use on dogs with compromised renal function has not been studied; 3) in simultaneous administration with drugs that suppress the P-450 enzyme system, such as azoles (e.g. ketoconazole), that may lead to increased plasma levels of cyclosporine. Killed vaccines are recommended for dogs receiving CYCLAVANCE Oral Solution for Dogs because the impact of cyclosporine on the immune response to modified live vaccines has not been evaluated. For full prescribing information, contact Virbac at 1-800-338-3659 or view the
Product Insert.
References:
1. CYCLAVANCE (cyclosporine oral solution) USP MODIFIED [product label]. Fort Worth, TX: Virbac AH, Inc.; 2020.
2. Navarro C, Crastes N, Benizeau E, McGahie D. Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies. Ir Vet J. 2015;68:3.
3. Steffan J, Parks C, Seewald W. North American Veterinary Dermatology Cyclosporine Study Group. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. J Am Vet Med Assoc. 2005;226:1855–1863.
WARNING: This product can expose you to cyclosporine, which is known to the State of California to cause cancer. For more information go to
www.P65Warnings.ca.gov.
Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer.
For
Dogs
Drug class
Immunosuppressant, Oral solution
Ingredients
Active ingredient(s):
Cyclosporine (USP Modified)
Inactive ingredients:
Complete inactive ingredients list not provided by manufacturer.
Product flavoring
The manufacturer does not specify the exact flavor of this product.
Product strength & size
CYCLAVANCE is supplied in glass amber vials of 15 and 50 mL at 100 mg/mL. A dispensing system is included (see Product Insert for additional information).
-
15 mL vials are supplied with a 1 mL Luer-Lok oral dosing syringe.
-
50 mL vials are supplied with a 1 mL and 3 mL Luer-Lok oral dosing syringes.
Please ensure the selected product and quantity are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above.
Usage
CYCLAVANCE Oral Solution should be administered as directed by your veterinarian. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. If you have questions about your pet’s prescribed dosing schedule (e.g., timing, interval), please contact your veterinarian.
-
Wear gloves during administration.
-
Wash hands after administration.
Manufacturer Dosage and Administration*
CYCLAVANCE should be given according to your veterinarian’s instructions. Your veterinarian will tell you what amount of CYCLAVANCE is right for your dog. CYCLAVANCE should be given at least one hour before or two hours after a meal.
Do not change the way you give CYCLAVANCE to your dog without first speaking with your veterinarian. If a dose is missed, the next dose should be administered (without doubling) as soon as possible, but dosing should be no more frequent than once daily. Do not rinse or clean the oral dosing syringe between uses.
Review the manufacturer’s Instructions for Assembling the Dispensing System and Preparing a Dose of CYCLAVANCE and the Information
for Dog Owners sheet prior to using this medication.
*Additional information may be provided within the manufacturer’s full Prescribing Information. Always follow the specific instructions provided by your veterinarian regarding your pet's care.
Storage
-
CYCLAVANCE (cyclosporine oral solution) USP MODIFIED should be stored and dispensed in the original container at temperatures between 68°-86°F.
-
Keep this and all other medications in a secure location out of the reach of children and animals.
-
Do not refrigerate because a precipitate may be observed below 68°F.
-
Once opened, use contents within 12 weeks.
-
Exposure to extreme temperatures, light, or moisture can affect the integrity and effectiveness of medications. Always store this medication properly (e.g., away from the bathroom, kitchen sink, or other damp places), as outlined on the product label.
Side effects
For additional information and guidance regarding the potential side effects of this product, please refer to the manufacturer’s full Prescribing Information or consult your veterinarian.
CYCLAVANCE, like all other drugs, may cause some side effects in individual dogs. These are normally mild, but serious side effects have been reported in dogs taking CYCLAVANCE. Serious side effects can, in rare situations, result in death. It is important to stop the medication and contact your veterinarian immediately if you think your dog may have a medical problem or side effect while on CYCLAVANCE.
In clinical studies, the most commonly reported side effect for cyclosporine was vomiting and diarrhea. In most cases, the vomiting and diarrhea stopped with continued use or dose modification. Persistent otitis externa, urinary tract infection, anorexia, lethargy, gingival hyperplasia and lymphadenopathy were the next most frequent side effects observed. Persistent, progressive weight loss may be associated with more serious side effects. You should monitor your dog’s appetite and body weight. If you think that your dog is losing weight, you should contact your veterinarian. CYCLAVANCE may increase susceptibility to infection and to the development of tumors.
Contact your veterinarian immediately if you observe any of the following side effects, as they may indicate that your pet is not responding appropriately to or is experiencing an issue related to this medication:
-
Swelling/overgrowth of the gums
-
Significant or ongoing weight loss
-
Any signs of serious illness or infection (e.g., fever, chills, frequent or painful urination)
The information provided above may not encompass all possible side effects. Please notify your veterinarian if your pet experiences any side effects, including those listed above, or if you notice anything unusual.
Precautions
Before using this product, please review the manufacturer’s full Prescribing Information for any relevant warnings and safety precautions.
-
For oral use in dogs only.
-
Not for human use. Keep this and all other medications out of reach of children and animals.
-
Do not eat, drink, smoke, or use smokeless tobacco while handling CYCLAVANCE. In case of accidental ingestion, seek medical advice immediately and provide the package insert or the label to the physician. People with known hypersensitivity to cyclosporine should avoid contact with CYCLAVANCE.
-
CYCLAVANCE (cyclosporine oral solution) is a systemic immunosuppressant that may increase susceptibility to infection and the development of neoplasia (cancer or other abnormal tissue growth).
-
Do not use CYCLAVANCE in dogs with a history of neoplasia/cancer or seizures.
-
The safety and effectiveness of cyclosporine has not been established in dogs less than 6 months of age or less than 4 lbs body weight. CYCLAVANCE is not for use in breeding, pregnant, or lactating dogs.
-
Use with caution in dogs with a history of diabetes mellitus or renal insufficiency.
Do not administer this medication to animals with a known or suspected allergy/hypersensitivity to it or any of its ingredients. Allergic reactions to medications may occur. Please inform Vetsource and your veterinarian if your pet has any known sensitivities or allergies, especially to medications and supplements.
If your pet displays symptoms of an allergic reaction, discontinue therapy and call your veterinarian immediately or seek emergency veterinary attention. Symptoms may include (but are not limited to): swollen lips, tongue, face, or airways; difficulty breathing; agitation; profuse salivation; and widespread hives or itching.
Human exposure warning
This medication is classified as hazardous due to potential exposure risks in humans. Proper use of personal protective equipment (PPE) is recommended when handling this medication to minimize the risk of exposure. Wear gloves when handling this medication and wash hands thoroughly with soap and water afterward (even if gloves are worn).
Food and drug interactions
CYCLAVANCE should not be given with other drugs that may lower the immune response.
CYCLAVANCE should be used with caution with drugs that affect the P-450 enzyme system. Simultaneous administration of CYCLAVANCE with drugs that suppress the P-450 enzyme system, such as azoles (e.g. ketoconazole), may lead to increased plasma levels of cyclosporine.
Killed vaccines are recommended for dogs receiving CYCLAVANCE because the impact of cyclosporine on the immune response to modified live vaccines is unknown.
The following drugs* may have potential interactions with this medication:
ACE inhibitors (e.g., benazepril), azole antifungals (e.g., ketoconazole), calcium channel blockers (e.g., diltiazem), corticosteroids (e.g., dexamethasone, prednisone), digoxin, estriol (Incurin), JAK inhibitors (e.g., oclacitinib [Apoquel]), loop diuretics (e.g., furosemide [Salix]), methotrexate, metronidazole, mycophenolate, NSAIDs, phenobarbital, sirolimus, spironolactone, sulfa antibiotics, telmisartan (Semintra), and warfarin.
Please ensure your veterinarian is aware of all medications, supplements, and over-the-counter (OTC) products that your pet is currently using. Your veterinarian may prescribe multiple medications, even if a potential drug interaction may occur. In these instances, your veterinarian may adjust the dosages or monitor more closely. Contact your veterinarian if your pet experiences any unusual reactions when multiple medications and/or supplements are given together.
*The information provided in this product description does not contain all possible drug interactions. Consult your veterinarian if you have any questions or concerns prior to using this medication.
Adverse reactions
If you are concerned that your pet has experienced an adverse reaction to this medication, please contact Virbac AH at 1-800-338-3659 or Vetsource Pet Owner Care at 877-738-4443.
Overdose
If you have any reason to suspect accidental ingestion or overdose, call your doctor/veterinarian or the appropriate poison control resource immediately.
For humans:
-
The national toll-free Poison Help line, 1-800-222-1222, will connect you to your local poison center in case of emergency. This service is available nationwide and in most U.S. territories.
For animals:
-
The ASPCA Animal Poison Control Center is available 24 hours a day, 365 days a year at 888-426-4435.
-
Pet Poison Helpline also provides a 24/7 animal poison control service at 855-764-7661.
Please note: The contact information provided above is for third-party services in the event of a potential poison-related emergency. Consultation fees may apply for these services.
Disclaimer: The content provided on this page is NOT medical advice.
All content, including the images and product description above, is intended for general informational purposes only and should not be considered a substitute for professional veterinary consultation, diagnosis, or treatment. For additional information about this product and how it fits into your pet's individual treatment plan, please consult your veterinarian.
Last revised: 11/10/2026